메뉴 건너뛰기




Volumn 24, Issue 13, 2010, Pages

Radiation therapy in the management of diffuse large b-cell lymphoma: Still relevant?

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; IFOSFAMIDE; METHOTREXATE; PREDNISONE; RITUXIMAB; VINCRISTINE; VINDESINE;

EID: 78650784358     PISSN: 08909091     EISSN: 08909091     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (9)

References (46)
  • 1
    • 0031927984 scopus 로고    scopus 로고
    • New approach to classifying non-hodgkins lymphomas: Clinical features of the major histologic subtypes. Non-hodgkins lymphoma classification project
    • Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkins lymphomas: clinical features of the major histologic subtypes. Non-Hodgkins Lymphoma Classification Project. J Clin Oncol. 1998;16:2780-95.
    • (1998) J Clin Oncol , vol.16 , pp. 2780-2795
    • Armitage, J.O.1    Weisenburger, D.D.2
  • 2
    • 9144237554 scopus 로고    scopus 로고
    • Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
    • Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275-82.
    • (2004) Blood , vol.103 , pp. 275-282
    • Hans, C.P.1    Weisenburger, D.D.2    Greiner, T.C.3
  • 3
    • 57149089307 scopus 로고    scopus 로고
    • Stromal gene signatures in large-B-cell lymphomas
    • Lenz G, Wright G, Dave SS, et al. Stromal gene signatures in large-B-cell lymphomas. N Engl J Med. 2008;359:2313-23.
    • (2008) N Engl J Med , vol.359 , pp. 2313-2323
    • Lenz, G.1    Wright, G.2    Dave, S.S.3
  • 4
    • 0027409814 scopus 로고
    • Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low-grade and intermediate-grade non-Hodgkin lymphoma. Results of a prospective randomized study
    • Yahalom J, Varsos G, Fuks Z, et al. Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low-grade and intermediate-grade non-Hodgkin lymphoma. Results of a prospective randomized study. Cancer. 1993;71:2342-50.
    • (1993) Cancer , vol.71 , pp. 2342-2350
    • Yahalom, J.1    Varsos, G.2    Fuks, Z.3
  • 5
    • 0018717552 scopus 로고
    • CVP-remission-maintenance in stage I or II non-Hodgkins lymphomas: Preliminary results of a randomized study
    • Landberg TG, Hakansson LG, Moller TR, et al. CVP-remission-maintenance in stage I or II non-Hodgkins lymphomas: preliminary results of a randomized study. Cancer. 1979;44:831-8.
    • (1979) Cancer , vol.44 , pp. 831-838
    • Landberg, T.G.1    Hakansson, L.G.2    Moller, T.R.3
  • 6
    • 0018898424 scopus 로고
    • Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkins lymphoma
    • Monfardini S, Banfi A, Bonadonna G, et al. Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkins lymphoma. Intl J Rad Oncol Biol Phys. 1980;6:125-34.
    • (1980) Intl J Rad Oncol Biol Phys , vol.6 , pp. 125-134
    • Monfardini, S.1    Banfi, A.2    Bonadonna, G.3
  • 7
    • 0020619345 scopus 로고
    • A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I-II non-Hodgkins lymphomas
    • Nissen NI, Ersboll J, Hansen HS, et al. A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I-II non-Hodgkins lymphomas. Cancer. 1983;52:1-7.
    • (1983) Cancer , vol.52 , pp. 1-7
    • Nissen, N.I.1    Ersboll, J.2    Hansen, H.S.3
  • 8
    • 23044503407 scopus 로고    scopus 로고
    • Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: A study by the groupe detude des lymphomes de ladulte
    • Feugier P, Van Hoof A, Sebban C, et al. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe dEtude des Lymphomes de lAdulte. J Clin Oncol. 2005;23:4117-26.
    • (2005) J Clin Oncol , vol.23 , pp. 4117-4126
    • Feugier, P.1    Van Hoof, A.2    Sebban, C.3
  • 9
    • 33745982067 scopus 로고    scopus 로고
    • Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma
    • Habermann TM, Weller EA, Morrison VA, et al. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol. 2006;24:3121-7.
    • (2006) J Clin Oncol , vol.24 , pp. 3121-3127
    • Habermann, T.M.1    Weller, E.A.2    Morrison, V.A.3
  • 10
    • 0022634894 scopus 로고
    • Factors predicting survival in adults with stage I and II large-cell lymphoma treated with primary radiation therapy
    • Kaminski MS, Coleman CN, Colby TV, et al. Factors predicting survival in adults with stage I and II large-cell lymphoma treated with primary radiation therapy. Ann Int Med. 1986;104:747-56.
    • (1986) Ann Int Med , vol.104 , pp. 747-756
    • Kaminski, M.S.1    Coleman, C.N.2    Colby, T.V.3
  • 11
    • 0028352295 scopus 로고
    • Clinical stage 1 non-Hodgkins lymphoma: Long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy
    • Vaughan Hudson B, Vaughan Hudson G, MacLennan KA, et al. Clinical stage 1 non-Hodgkins lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy. Br J Cancer. 1994;69:1088-93.
    • (1994) Br J Cancer , vol.69 , pp. 1088-1093
    • Vaughan Hudson, B.1    Vaughan Hudson, G.2    MacLennan, K.A.3
  • 12
    • 0018742213 scopus 로고
    • Results of radiotherapy in control of stage I and II non-Hodgkins lymphoma
    • Chen MG, Prosnitz LR, Gonzalez-Serva A, Fischer DB. Results of radiotherapy in control of stage I and II non-Hodgkins lymphoma. Cancer. 1979;43:1245-54.
    • (1979) Cancer , vol.43 , pp. 1245-1254
    • Chen, M.G.1    Prosnitz, L.R.2    Gonzalez-Serva, A.3    Fischer, D.B.4
  • 13
    • 4143102674 scopus 로고    scopus 로고
    • Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkins lymphoma: Eastern Cooperative Oncology Group study 1484
    • Horning SJ, Weller E, Kim K, et al. Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkins lymphoma: Eastern Cooperative Oncology Group study 1484. J Clin Oncol. 2004;22:3032-8.
    • (2004) J Clin Oncol , vol.22 , pp. 3032-3038
    • Horning, S.J.1    Weller, E.2    Kim, K.3
  • 14
    • 33947543250 scopus 로고    scopus 로고
    • CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: A study by the Groupe dEtude des Lymphomes de lAdulte
    • Bonnet C, Fillet G, Mounier N, et al. CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: a study by the Groupe dEtude des Lymphomes de lAdulte. J Clin Oncol. 2007;25:787-92.
    • (2007) J Clin Oncol , vol.25 , pp. 787-792
    • Bonnet, C.1    Fillet, G.2    Mounier, N.3
  • 15
    • 0032474694 scopus 로고    scopus 로고
    • Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkins lymphoma
    • Miller TP, Dahlberg S, Cassady JR, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkins lymphoma. N Engl J Med. 1998;339:21-6.
    • (1998) N Engl J Med , vol.339 , pp. 21-26
    • Miller, T.P.1    Dahlberg, S.2    Cassady, J.R.3
  • 16
    • 0003242248 scopus 로고    scopus 로고
    • CHOP alone compared to CHOP plus radiotherapy for early stage aggressive non-Hodgkins lymphomas: Update of the Southwest Oncology Group (SWOG) randomized trial
    • Miller TP, LeBlanc M, Spier C. CHOP alone compared to CHOP plus radiotherapy for early stage aggressive non-Hodgkins lymphomas: Update of the Southwest Oncology Group (SWOG) randomized trial. Blood. 2001;98:724.
    • (2001) Blood , vol.98 , pp. 724
    • Miller, T.P.1    LeBlanc, M.2    Spier, C.3
  • 17
    • 20144369743 scopus 로고    scopus 로고
    • ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma
    • Reyes F, Lepage E, Ganem G, et al. ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma. N Engl J Med. 2005;352:1197-205.
    • (2005) N Engl J Med , vol.352 , pp. 1197-1205
    • Reyes, F.1    Lepage, E.2    Ganem, G.3
  • 18
    • 68449101743 scopus 로고    scopus 로고
    • (IELSG 4). [corrected]
    • Martinelli G, Gigli F, Calabrese L, et al. Early stage gastric diffuse large B-cell lymphomas: results of a randomized trial comparing chemotherapy alone versus chemotherapy + involved field radiotherapy. (IELSG 4). [corrected]. Leukem Lymphoma. 2009;50:925-31.
    • (2009) Leukem Lymphoma , vol.50 , pp. 925-931
    • Martinelli, G.1    Gigli, F.2    Calabrese, L.3
  • 19
    • 44249092120 scopus 로고    scopus 로고
    • Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014
    • Persky DO, Unger JM, Spier CM, et al. Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014. J Clin Oncol. 2008;26:2258-63.
    • (2008) J Clin Oncol , vol.26 , pp. 2258-2263
    • Persky, D.O.1    Unger, J.M.2    Spier, C.M.3
  • 20
    • 77957940539 scopus 로고    scopus 로고
    • Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy
    • Phan J, Mazloom A, Medeiros J, et al. Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy. J Clin Oncol. 2010;28:4170-6.
    • (2010) J Clin Oncol. , vol.28 , pp. 4170-4176
    • Phan, J.1    Mazloom, A.2    Medeiros, J.3
  • 21
    • 23044453180 scopus 로고    scopus 로고
    • Role of positron emission tomography in lymphoma
    • Juweid ME, Cheson BD. Role of positron emission tomography in lymphoma. J Clin Oncol. 2005;23:4577-80.
    • (2005) J Clin Oncol , vol.23 , pp. 4577-4580
    • Juweid, M.E.1    Cheson, B.D.2
  • 22
    • 24044553298 scopus 로고    scopus 로고
    • FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma
    • Mikhaeel NG, Hutchings M, Fields PA, et al. FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma. Ann Oncol. 2005;16:1514-23.
    • (2005) Ann Oncol , vol.16 , pp. 1514-1523
    • Mikhaeel, N.G.1    Hutchings, M.2    Fields, P.A.3
  • 23
    • 0035863387 scopus 로고    scopus 로고
    • Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkins lymphoma: Is [18F] FDG-PET a valid alternative to conventional diagnostic methods?
    • Spaepen K, Stroobants S, Dupont P, et al. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkins lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods? J Clin Oncol. 2001;19:414-9.
    • (2001) J Clin Oncol , vol.19 , pp. 414-419
    • Spaepen, K.1    Stroobants, S.2    Dupont, P.3
  • 24
    • 78650763342 scopus 로고    scopus 로고
    • Positive PET prior to consolidative radiation therapy increases risk of in-field failure in diffuse large B-cell lymphoma
    • Dorth J, Chino J, Prosnitz L, Kelsey C. Positive PET prior to consolidative radiation therapy increases risk of in-field failure in diffuse large B-cell lymphoma. Proceedings of ASTRO; IJROBP. 2009;75:S64.
    • (2009) Proceedings of ASTRO; IJROBP , vol.75
    • Dorth, J.1    Chino, J.2    Prosnitz, L.3    Kelsey, C.4
  • 25
    • 0025338858 scopus 로고
    • Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas
    • Lavey RS, Eby NL, Prosnitz LR. Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas. Cancer. 1990;66:80-8.
    • (1990) Cancer , vol.66 , pp. 80-88
    • Lavey, R.S.1    Eby, N.L.2    Prosnitz, L.R.3
  • 26
    • 24944474897 scopus 로고    scopus 로고
    • Second primary malignancies after treatment for malignant lymphoma
    • Okines A, Thomson CS, Radstone CR, et al. Second primary malignancies after treatment for malignant lymphoma. Br J Cancer. 2005;93:418-24.
    • (2005) Br J Cancer , vol.93 , pp. 418-424
    • Okines, A.1    Thomson, C.S.2    Radstone, C.R.3
  • 27
    • 0027394689 scopus 로고
    • Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkins lymphoma
    • Fisher RI, Gaynor ER, Dahlberg S, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkins lymphoma. N Engl J Med. 1993;328:1002-6.
    • (1993) N Engl J Med , vol.328 , pp. 1002-1006
    • Fisher, R.I.1    Gaynor, E.R.2    Dahlberg, S.3
  • 28
    • 0030973746 scopus 로고    scopus 로고
    • High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma
    • Gianni AM, Bregni M, Siena S, et al. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. N Engl J Med. 1997;336:1290-7.
    • (1997) N Engl J Med , vol.336 , pp. 1290-1297
    • Gianni, A.M.1    Bregni, M.2    Siena, S.3
  • 29
    • 0028062747 scopus 로고
    • Adjuvant radiotherapy to sites of previous bulky disease in patients stage IV diffuse large cell lymphoma
    • Aviles A, Delgado S, Nambo MJ, et al. Adjuvant radiotherapy to sites of previous bulky disease in patients stage IV diffuse large cell lymphoma. Intl J Rad Oncol Biol Phys. 1994;30:799-803.
    • (1994) Intl J Rad Oncol Biol Phys , vol.30 , pp. 799-803
    • Aviles, A.1    Delgado, S.2    Nambo, M.J.3
  • 30
    • 2542555752 scopus 로고    scopus 로고
    • Adjuvant radiotherapy in stage IV diffuse large cell lymphoma improves outcome
    • Aviles A, Fernandezb R, Perez F, et al. Adjuvant radiotherapy in stage IV diffuse large cell lymphoma improves outcome. Leukem Lymphoma. 2004;45:1385-9.
    • (2004) Leukem Lymphoma , vol.45 , pp. 1385-1389
    • Aviles, A.1    Fernandezb, R.2    Perez, F.3
  • 31
    • 0034110840 scopus 로고    scopus 로고
    • Consolidation radiotherapy to bulky or semibulky lesions in the management of stage III-IV diffuse large B cell lymphomas
    • Ferreri AJ, DellOro S, Reni M, et al. Consolidation radiotherapy to bulky or semibulky lesions in the management of stage III-IV diffuse large B cell lymphomas. Oncol. 2000;58:219-26.
    • (2000) Oncol , vol.58 , pp. 219-226
    • Ferreri, A.J.1    DellOro, S.2    Reni, M.3
  • 32
    • 0034333172 scopus 로고    scopus 로고
    • Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas
    • Schlembach PJ, Wilder RB, Tucker SL, et al. Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas. Intl J Rad Oncol Biol Phys. 2000;48:1107-10.
    • (2000) Intl J Rad Oncol Biol Phys , vol.48 , pp. 1107-1110
    • Schlembach, P.J.1    Wilder, R.B.2    Tucker, S.L.3
  • 34
    • 33947512956 scopus 로고    scopus 로고
    • Use of positron emission tomography for response assessment of lymphoma: Consensus of the imaging subcommittee of international harmonization project in lymphoma
    • Juweid ME, Stroobants S, Hoekstra OS, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol. 2007;25:571-8.
    • (2007) J Clin Oncol , vol.25 , pp. 571-578
    • Juweid, M.E.1    Stroobants, S.2    Hoekstra, O.S.3
  • 35
    • 0028790440 scopus 로고
    • Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkins lymphoma
    • Philip T, Guglielmi C, Hagenbeek A, et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkins lymphoma. N Engl J Med. 1995;333:1540-5.
    • (1995) N Engl J Med , vol.333 , pp. 1540-1545
    • Philip, T.1    Guglielmi, C.2    Hagenbeek, A.3
  • 36
    • 77950579581 scopus 로고    scopus 로고
    • Involved field radiation after autologous stem cell transplant for diffuse large B-cell lymphoma in the rituximab era
    • Biswas T, Dhakal S, Chen R, et al. Involved field radiation after autologous stem cell transplant for diffuse large B-cell lymphoma in the rituximab era. Intl J Rad Oncol Biol Phys.77:79-85.
    • Intl J Rad Oncol Biol Phys , vol.77 , pp. 79-85
    • Biswas, T.1    Dhakal, S.2    Chen, R.3
  • 37
    • 67649884048 scopus 로고    scopus 로고
    • The role of FDG-PET imaging and involved field radiotherapy in relapsed or refractory diffuse large B-cell lymphoma
    • Hoppe BS, Moskowitz CH, Zhang Z, et al. The role of FDG-PET imaging and involved field radiotherapy in relapsed or refractory diffuse large B-cell lymphoma. Bone Marrow Transplant. 2009;43:941-8.
    • (2009) Bone Marrow Transplant , vol.43 , pp. 941-948
    • Hoppe, B.S.1    Moskowitz, C.H.2    Zhang, Z.3
  • 38
    • 0030986405 scopus 로고    scopus 로고
    • High dose chemotherapy and stem cell rescue for aggressive non-Hodgkins lymphoma: Pattern of failure and implications for involved-field radiotherapy
    • Mundt AJ, Williams SF, Hallahan D. High dose chemotherapy and stem cell rescue for aggressive non-Hodgkins lymphoma: pattern of failure and implications for involved-field radiotherapy. Intl J Rad Oncol Biol Phys. 1997;39:617-25.
    • (1997) Intl J Rad Oncol Biol Phys , vol.39 , pp. 617-625
    • Mundt, A.J.1    Williams, S.F.2    Hallahan, D.3
  • 39
    • 17144438222 scopus 로고    scopus 로고
    • Autotransplantation for relapsed or refractory non-Hodgkins lymphoma (NHL): Long-term follow-up and analysis of prognostic factors
    • Rapoport AP, Lifton R, Constine LS, et al. Autotransplantation for relapsed or refractory non-Hodgkins lymphoma (NHL): long-term follow-up and analysis of prognostic factors. Bone Marrow Transplant. 1997;19:883-90.
    • (1997) Bone Marrow Transplant , vol.19 , pp. 883-890
    • Rapoport, A.P.1    Lifton, R.2    Constine, L.S.3
  • 40
    • 46749092108 scopus 로고    scopus 로고
    • Consolidative involved field radiotherapy after high dose chemotherapy and autologous stem cell transplantation for non-Hodgkins lymphoma: A case-control study
    • Oehler-Janne C, Taverna C, Stanek N, et al. Consolidative involved field radiotherapy after high dose chemotherapy and autologous stem cell transplantation for non-Hodgkins lymphoma: a case-control study. Hematol Oncol. 2008;26:82-90.
    • (2008) Hematol Oncol , vol.26 , pp. 82-90
    • Oehler-Janne, C.1    Taverna, C.2    Stanek, N.3
  • 41
    • 23644439927 scopus 로고    scopus 로고
    • Effective palliation by low dose local radiotherapy for recurrent and/or chemotherapy refractory non-follicular lymphoma patients
    • Haas RL, Poortmans P, de Jong D, et al. Effective palliation by low dose local radiotherapy for recurrent and/or chemotherapy refractory non-follicular lymphoma patients. Eur J Cancer. 2005;41:1724-30.
    • (2005) Eur J Cancer , vol.41 , pp. 1724-1730
    • Haas, R.L.1    Poortmans, P.2    De Jong, D.3
  • 42
    • 60849120820 scopus 로고    scopus 로고
    • Efficacy of palliative low-dose involved-field radiation therapy in advanced lymphoma: A phase II study
    • Murthy V, Thomas K, Foo K, et al. Efficacy of palliative low-dose involved-field radiation therapy in advanced lymphoma: a phase II study. Clin Lymphoma Myeloma. 2008;8:241-5.
    • (2008) Clin Lymphoma Myeloma , vol.8 , pp. 241-245
    • Murthy, V.1    Thomas, K.2    Foo, K.3
  • 43
    • 0035863505 scopus 로고    scopus 로고
    • Autologous transplantation for diffuse aggressive non-hodgkins lymphoma in patients never achieving remission: A report from the autologous blood and marrow transplant registry
    • Vose JM, Zhang MJ, Rowlings PA, et al. Autologous transplantation for diffuse aggressive non-Hodgkins lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. J Clin Oncol. 2001;19:406-13.
    • (2001) J Clin Oncol , vol.19 , pp. 406-413
    • Vose, J.M.1    Zhang, M.J.2    Rowlings, P.A.3
  • 44
    • 0034785277 scopus 로고    scopus 로고
    • The impact of external beam radiation therapy prior to autologous bone marrow transplantation in patients with non-Hodgkins lymphoma
    • Friedberg JW, Neuberg D, Monson E, et al. The impact of external beam radiation therapy prior to autologous bone marrow transplantation in patients with non-Hodgkins lymphoma. Biol Blood Marrow Transplant. 2001;7:446-53.
    • (2001) Biol Blood Marrow Transplant , vol.7 , pp. 446-453
    • Friedberg, J.W.1    Neuberg, D.2    Monson, E.3
  • 45
    • 34147135138 scopus 로고    scopus 로고
    • The impact of involved field radiation therapy in the treatment of relapsed or refractory non-Hodgkin lymphoma with high-dose chemotherapy followed by hematopoietic progenitor cell transplant
    • Wendland MM, Smith DC, Boucher KM, et al. The impact of involved field radiation therapy in the treatment of relapsed or refractory non-Hodgkin lymphoma with high-dose chemotherapy followed by hematopoietic progenitor cell transplant. Am J Clin Oncol. 2007;30:156-62.
    • (2007) Am J Clin Oncol , vol.30 , pp. 156-162
    • Wendland, M.M.1    Smith, D.C.2    Boucher, K.M.3
  • 46
    • 0034307538 scopus 로고    scopus 로고
    • High-dose chemoradiotherapy and autologous stem cell transplantation for patients with primary refractory aggressive non-Hodgkin lymphoma: An intention-to-treat analysis
    • Kewalramani T, Zelenetz AD, Hedrick EE, et al. High-dose chemoradiotherapy and autologous stem cell transplantation for patients with primary refractory aggressive non-Hodgkin lymphoma: an intention-to-treat analysis. Blood. 2000;96:2399-404.
    • (2000) Blood , vol.96 , pp. 2399-2404
    • Kewalramani, T.1    Zelenetz, A.D.2    Hedrick, E.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.